Chronic inhaled nitric oxide: Effects on pulmonary vascular endothelial function and pathology in rats

Journal of Applied Physiology

Volumn 80, Issue 1, 1996, Pages 252-260

  Roos, Christine M ^a   Frank, Deborah U ^a   Xue, Chun ^a   Johns, Roger A ^a   Rich, George F ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

chronic hypoxia; endothelium derived relaxing factor; nitric oxide synthase; normoxia; pulmonary hypertension; vascular remodeling

Indexed keywords

BRADYKININ; N(G) NITROARGININE METHYL ESTER; OXYGEN;

ANIMAL MODEL; ANIMAL TISSUE; ARTERY MEDIA; ARTICLE; CONTROLLED STUDY; HEART RIGHT VENTRICLE HYPERTROPHY; HYPOXIC LUNG VASOCONSTRICTION; ISOLATED LUNG; LUNG ARTERY; LUNG ARTERY PRESSURE; LUNG ENDOTHELIUM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030041523     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.1996.80.1.252     Document Type: Article

References (38)

1. Adnot, S., E. Raffestin, S. Eddahibi, P. Braquet, and P. Chabrier. Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. J. Clin. Invest. 87: 155-162, 1991.
2. Audi, S. H., C. A. Dawson, D. A. Rickaby, and J. H. Linehan. Localization of the sites of pulmonary vasomotion by use of arterial and venous occlusion. J. Appl. Physiol. 70: 2126-2136, 1991.
3. Axelsson, K. L., and R. G. G. Andersson. Tolerance towards nitroglycerin, induced in vivo, is correlated to a reduced cGMP response and an alteration in cGMP turnover. Eur. J. Pharmacol. 88: 71-79, 1983.
4. Barer, G., C. Emery, A. Stewart, D. Bee, and P. Howard. Endothelial control of the pulmonary circulation in normal and chronically hypoxic rats. J. Physiol. Lond. 463: 1-16, 1993.
5. Earth, P. J., C. Kimpel, S. Roy, and U. Wagner. An improved mathematical approach for the assessment of the medial thickness of pulmonary arteries. Pathol. Res. Pract. 189: 567-576, 1993.
6. Buga, G. M., J. M. Griscavage, N. E. Rogers, and L. J. Ignarro. Negative feedback regulation of endothelial cell function by nitric oxide. Circ. Res. 73: 808-812, 1993.
7. Bult, H., G. R. Y. De Meyer, F. H. Jordaens, and A. G. Herman. Chronic exposure of exogenous nitric oxide may suppress its endogenous release and efficacy. Cardiovasc. Pharmacol. 17, Suppl. 3: S79-S82, 1991.
8. Chang, L. Y., J. A. Graham, F. J. Miller, J. J. Ospital, and J. D. Crapo. Effects of subchronic inhalation of low concentrations of nitrogen dioxide. Toxicol. Appl. Pharmacol. 83: 46-61, 1986.
9. Dinh-Xuan, A. T., J. Pepke-Zaba, A. Y. Butt, G. Cremona, and T. W. Hlgenbottam. Impairment of pulmonary-artery endothelium-dependent relaxation in chronic obstructive lung disease is not due to dysfunction of endothelial cell membrane receptors nor to L-arginine deficiency. Br. J. Pharmacol. 109: 587-591, 1993.
10. Frostell, C. G., H. Blomqvist, G. Hedenstierna, J. Lundberg, and W. M. Zapol. Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology 78: 427-435, 1993.
11. Frostell, C., M. D. Fratacci, J. C. Wain, R. Jones, and W. M. Zapol. Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 83: 2038-2047, 1991.
12. Garg, U. C., and A. Hassid. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 83: 1774-1777, 1989.
13. Gerlach, H., D. Pappert, K. Lewandowski, R. Rossaint, and K. J. Falke. Long-term inhalation with evaluated low doses of nitric oxide for selective improvement of oxygenation in patients with adult respiratory distress syndrome. Intensive Care Med. 19: 443-449, 1993.
14. Hampl, V., S. L. Archer, D. P. Nelson, and E. K. Weir. Chronic EDRF inhibition and hypoxia: effects on pulmonary circulation and systemic blood pressure. J. Appl. Physiol. 75: 1748-1757, 1993.
15. Hassid, A., H. Arabshahi, T. Bourcier, G. S. Dhaunsi, and C. Matthews. Nitric oxide selectively amplifies FGF2-induced mitogenesis in primary rat aortic smooth muscle cells. Am. J. Physiol. 267 (Heart Circ. Physiol. 36): H1040-H1048, 1994.
16. Hassoun, P. M., B. T. Thompson, and C. A. Hales. Partial reversal of hypoxic pulmonary hypertension by heparin. Am. Rev. Respir. Dis. 145: 193-196, 1992.
17. Hugod, C. Effect of exposure to 43 ppm nitric oxide and 3.6 ppm nitrogen dioxide on rabbit lung. Int. Arch. Occup. Environ. Health 42: 159-167, 1979.
18. Isaacson, T. C., V. Hampl, E. K. Weir, D. P. Nelson, and S. L. Archer. Increased endothelium-derived NO in hypertensive pulmonary circulation of chronically hypoxic rats. J. Appl. Physiol. 76: 933-940, 1994.
19. Kourembanas, S., L. P. McQuillan, G. K. Leung, and D. V. Faller. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J. Clin. Invest. 92: 99-104, 1993.
20. Kouyoumdjian, C., S. Adnot, M. Levame, S. Eddahibi, H. Bousbaa, and B. Raffestin. Continuous inhalation of nitric oxide protects against development of pulmonary hypertension in chronically hypoxic rats. J. Clin. Invest. 94: 578-584, 1994.
21. Kurose, I., R. Wolf, M. B. Grisham, T. Y. Aw, R. D. Specian, and D. N. Granger. Microvascular responses to inhibition of nitric oxide production: role of active oxidants. Circ. Res. 76: 30-39, 1995.
22. Mayhan, W. G. Role of nitric oxide in modulating permeability of hamster cheek pouch in response to adenosine 5′-diphosphate and bradykinin. Inflammation 16: 295-305, 1992.
23. Moncada, S., and A. Higgs. The L-arginine-nitric oxide pathway. N. Engl J. Med. 329: 2002-2012, 1993.
24. Oka, M., K. Hasunuma, S. A. Webb, T. J. Stelzner, D. M. Rodman, and I. F. McMurtry. EDRF suppresses an unidentified vasoconstrictor mechanism in hypertensive rat lungs. Am. J. Physiol. 264 (Lung Cell. Mol. Physiol. 8): L587-L597, 1993.
25. Ono, S., J. Y. Westcott, and N. F. Voelkel. PAF antagonists inhibit pulmonary vascular remodeling induced by hypobaric hypoxia in rats. J. Appl. Physiol. 73: 1084-1092, 1992.
26. Orton, E. C., J. T. Reeves, and K. R. Stenmark. Pulmonary vasodilation with structurally altered pulmonary vessels and pulmonary hypertension. J. Appl. Physiol. 65: 2459-2467, 1988.
27. Pison, U., F. A. López, C. F. Heidelmeyer, R. Rossaint, and K. J. Falke. Inhaled nitric oxide reverses hypoxic pulmonary vasoconstriction without impairing gas exchange. J. Appl. Physiol. 74: 1287-1292, 1993.
28. Rabinovitch, M., W. Gamble, A. S. Nadas, O. S. Miettinen, and L. Reid. Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features. Am. J. Physiol. 236 (Heart Circ. Physiol. 5): H818-H827, 1979.
29. Rich, G. F., G. D. Murphy, C. M. Roos, and R. A. Johns. Inhaled nitric oxide: selective pulmonary vasodilation in cardiac surgical patients. Anesthesiology 78: 1028-1035, 1993.
30. Roberts, J. D., C. T. Roberts, R, C. Jones, W. M. Zapol, and K. D. Bloch. Continuous nitric oxide inhalation reduces pulmonary arterial structural changes, right ventricular hypertrophy, and growth retardation in the hypoxic newborn rat. Circ. Res. 76: 215-222, 1995.
31. Roos, C. M., G. F. Rich, D. R. Uncles, M. O. Daugherty, and D. U. Frank. Sites of vasodilation by inhaled nitric oxide vs. sodium nitroprusside in endothelin-constricted isolated rat lungs. J. Appl. Physiol. 77: 51-57, 1994.
32. Rossaint, R., K. J. Falke, F. Lopez, K. Slama, U. Pison, and W. M. Zapol. Inhaled nitric oxide for the adult respiratory distress syndrome. N. Engl. J. Med. 328: 399-405, 1993.
33. Rovira, I., T. Y. Chen, M. Winkler, N. Kawai, K. D. Bloch, and W. M. Zapol. Effects of inhaled nitric oxide on pulmonary hemodynamics and gas exchange in an ovine model of ARDS. J. Appl. Physiol. 76: 345-355, 1994.
34. Sessa, W. C., K. Pritchard, N. Seyedi, J. Wang, and T. H. Hintze. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ. Res. 74: 349-353, 1994.
35. Stanbrook, H. S., K. G. Morris, and I. F. McMurtry. Prevention and reversal of hypoxic pulmonary hypertension by calcium antagonists. Am. Rev. Respir. Dis. 130: 81-85, 1984.
36. Ujiie, K., L. Hogarth, R. Danziger, J. G. Drewett, P. S. T. Yuen, I. H. Pang, and R. A. Star. Homologous and heterologous desensitization of a guanylyl cyclase-linked nitric oxide receptor in cultured rat medullary interstitial cells. J. Pharmacol. Exp. Ther. 270: 761-767, 1994.
37. Xue, C., A. Rengasamy, T. D. Le Cras, P. A. Koberna, G. C. Dailey, and R. A. Johns. Distribution of NOS in normoxic vs. hypoxic rat lung: upregulation of NOS by chronic hypoxia. Am. J. Physiol. 267 (Lung Cell. Mol. Physiol. 11): L667-L678, 1994.
38. Yang, W., J. Ando, R. Korenaga, T. Toyo-oka, and A. Kamiya. Exogenous nitric oxide inhibits proliferation of cultured vascular endothelial cells. Biochem. Biophys. Res. Commun. 203: 1160-1167, 1994.